Testing SHR-9839 for advanced solid tumors
Treatments studied
Part of Cancer clinical trials.
This Phase 1 trial studies SHR-9839, a new injection medicine, for people with advanced solid tumors that can’t be removed by surgery and have returned or stopped responding to standard care. It mainly aims to find a safe dose and see early signs of whether the treatment can work.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have an advanced solid tumor that is not operable, and it’s come back or not responding, or there’s no standard treatment available
- You have at least one measurable tumor spot that can be tracked on scans
- Your daily function is good: you’re able to do most activities (ECOG 0–1)
- You’re expected to live at least 12 weeks
- Your blood counts and organ tests (like liver and kidneys) are adequate enough for treatment
- You can safely wait for treatment start and agree by signing informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new drug called SHR-4375 combined with other cancer treatments for people with advanced solid tumors that haven't gotten better with standard care. The goal is to see if the combination is safe and works against the cancer.
This study is testing a new drug called SHR-1049 for people with advanced solid tumors (cancers that have spread). It looks at safety, how the drug moves through the body, and whether it helps shrink tumors. You may be eligible if you have tried standard treatment without success or no standard treatment exists.
This study tests a new drug called SHR-9839 given under the skin, combined with other anti-cancer treatments, for people with solid tumors. The goal is to see if it is safe and effective.
This trial is testing an investigational drug called SHR-7787 for people with advanced solid tumors (cancer that has spread or can't be removed). The goal is to see if it is safe and how well it works. It may be an option if your tumor type is no longer responding to other treatments.
This trial tests a new drug called SHR-4610 for people with advanced solid tumors that have not responded to standard treatments. It aims to see if the drug is safe and effective, and may be an option if you have a measurable tumor and are generally in good health.
This study tests a new drug called SHR-8203 for people with advanced solid tumors that have stopped responding to standard treatments or have no treatment options. The goal is to see if the drug is safe and helps shrink or control the tumor.
Hear when a new Advanced Solid Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.